ZA766303B - Disubstituted phenol ethers of 3-amino-2-hydroxypropane processes for their preparation and their use as medicament - Google Patents
Disubstituted phenol ethers of 3-amino-2-hydroxypropane processes for their preparation and their use as medicamentInfo
- Publication number
- ZA766303B ZA766303B ZA766303A ZA766303A ZA766303B ZA 766303 B ZA766303 B ZA 766303B ZA 766303 A ZA766303 A ZA 766303A ZA 766303 A ZA766303 A ZA 766303A ZA 766303 B ZA766303 B ZA 766303B
- Authority
- ZA
- South Africa
- Prior art keywords
- hydroxypropane
- medicament
- amino
- processes
- preparation
- Prior art date
Links
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 150000008379 phenol ethers Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/36—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by carbon atoms having at least two bonds to oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/18—Fluorenes; Hydrogenated fluorenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19752547524 DE2547524A1 (de) | 1975-10-23 | 1975-10-23 | Disubstituierte phenolaether des 3-amino-2-hydroxypropans, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA766303B true ZA766303B (en) | 1977-09-28 |
Family
ID=5959934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA766303A ZA766303B (en) | 1975-10-23 | 1976-10-22 | Disubstituted phenol ethers of 3-amino-2-hydroxypropane processes for their preparation and their use as medicament |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US4110472A (sv) |
| JP (1) | JPS5935387B2 (sv) |
| AT (2) | AT345792B (sv) |
| AU (1) | AU502167B2 (sv) |
| BE (1) | BE847541A (sv) |
| BG (2) | BG31796A3 (sv) |
| CA (1) | CA1085417A (sv) |
| CH (2) | CH623562A5 (sv) |
| CS (2) | CS191322B2 (sv) |
| DD (1) | DD128555A5 (sv) |
| DE (1) | DE2547524A1 (sv) |
| DK (1) | DK480376A (sv) |
| ES (1) | ES452616A1 (sv) |
| FI (1) | FI67075C (sv) |
| FR (1) | FR2328458A1 (sv) |
| GB (1) | GB1497500A (sv) |
| GR (1) | GR61598B (sv) |
| HU (1) | HU174097B (sv) |
| IE (1) | IE43745B1 (sv) |
| IL (1) | IL50732A (sv) |
| LU (1) | LU76057A1 (sv) |
| NL (1) | NL7611683A (sv) |
| NO (1) | NO143844C (sv) |
| PL (2) | PL110002B1 (sv) |
| PT (1) | PT65737B (sv) |
| RO (1) | RO76883A (sv) |
| SE (1) | SE432926B (sv) |
| SU (2) | SU639443A3 (sv) |
| ZA (1) | ZA766303B (sv) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1223395B (it) * | 1987-12-01 | 1990-09-19 | Simes | Composti ad attivita' cardiovascolare |
| US5541204A (en) * | 1994-12-02 | 1996-07-30 | Bristol-Myers Squibb Company | Aryloxypropanolamine β 3 adrenergic agonists |
| US20090170841A1 (en) | 2007-04-20 | 2009-07-02 | Acucela Inc. | Styrenyl Derivative Compounds for Treating Ophthalmic Diseases and Disorders |
| FR3030514A1 (fr) * | 2014-12-18 | 2016-06-24 | Centre De Coop Int En Rech Agronomique Pour Le Dev (Cirad) | Dimeres polyaromatiques |
| EP3144289A1 (en) * | 2015-09-16 | 2017-03-22 | Evonik Technochemie GmbH | [(2-ethoxy-5-trans-1-propen-1-yl)-phenoxyl]-terminated compounds |
| KR20190096949A (ko) | 2016-10-05 | 2019-08-20 | 유니버시티 오브 피츠버그 - 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 | 소분자 ampk 활성화제 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3758583A (en) * | 1971-01-21 | 1973-09-11 | Syntex Corp | 2-(2-hydroxy-3-aminopropyl-1-yloxy)-1,6-dilfuoro-and-1,6-methano-{8 10{9 annulenes and the salts thereof |
-
1975
- 1975-10-23 DE DE19752547524 patent/DE2547524A1/de not_active Withdrawn
-
1976
- 1976-10-08 NO NO763442A patent/NO143844C/no unknown
- 1976-10-13 US US05/732,118 patent/US4110472A/en not_active Expired - Lifetime
- 1976-10-18 CH CH1318976A patent/CH623562A5/de not_active IP Right Cessation
- 1976-10-18 SU SU762413401A patent/SU639443A3/ru active
- 1976-10-19 AU AU18797/76A patent/AU502167B2/en not_active Expired
- 1976-10-19 BG BG7635324A patent/BG31796A3/xx unknown
- 1976-10-19 BG BG7634473A patent/BG27732A3/xx unknown
- 1976-10-20 IL IL50732A patent/IL50732A/xx unknown
- 1976-10-20 PT PT65737A patent/PT65737B/pt unknown
- 1976-10-21 NL NL7611683A patent/NL7611683A/xx not_active Application Discontinuation
- 1976-10-21 DD DD7600195393A patent/DD128555A5/xx unknown
- 1976-10-21 GB GB43725/76A patent/GB1497500A/en not_active Expired
- 1976-10-21 JP JP51125582A patent/JPS5935387B2/ja not_active Expired
- 1976-10-21 SE SE7611686A patent/SE432926B/sv unknown
- 1976-10-21 FI FI763010A patent/FI67075C/fi not_active IP Right Cessation
- 1976-10-21 HU HU76BA3468A patent/HU174097B/hu unknown
- 1976-10-21 AT AT606377A patent/AT345792B/de not_active IP Right Cessation
- 1976-10-21 AT AT784476A patent/AT344682B/de not_active IP Right Cessation
- 1976-10-22 RO RO7696832A patent/RO76883A/ro unknown
- 1976-10-22 PL PL1976213281A patent/PL110002B1/pl unknown
- 1976-10-22 ES ES452616A patent/ES452616A1/es not_active Expired
- 1976-10-22 CS CS766837A patent/CS191322B2/cs unknown
- 1976-10-22 PL PL1976193206A patent/PL110007B1/pl unknown
- 1976-10-22 BE BE171708A patent/BE847541A/xx not_active IP Right Cessation
- 1976-10-22 DK DK480376A patent/DK480376A/da not_active Application Discontinuation
- 1976-10-22 IE IE2332/76A patent/IE43745B1/en unknown
- 1976-10-22 CS CS777809A patent/CS191344B2/cs unknown
- 1976-10-22 GR GR51997A patent/GR61598B/el unknown
- 1976-10-22 FR FR7631948A patent/FR2328458A1/fr active Granted
- 1976-10-22 CA CA263,964A patent/CA1085417A/en not_active Expired
- 1976-10-22 LU LU76057A patent/LU76057A1/xx unknown
- 1976-10-22 ZA ZA766303A patent/ZA766303B/xx unknown
-
1977
- 1977-07-15 SU SU772502200A patent/SU664559A3/ru active
-
1980
- 1980-09-08 CH CH672680A patent/CH630058A5/de not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL50814A0 (en) | New phenol ethers their preparation and pharmaceutical compositions containing them | |
| PH12959A (en) | Preparation of pharmaceutical unit dosage form | |
| JPS51115910A (en) | Gradually releaseetype medical composition and its preparation | |
| EG12218A (en) | Process for preparing of novel diphenyl ethers and their use as insecticides | |
| GR61175B (en) | Preparation process of (1-phenyl-2-triazolyl-ethyl)-ether-derivatives and use thereof as fungicides | |
| JPS51146449A (en) | Preparation of novel cromanci compound and pharmaceutical composition | |
| IL50657A0 (en) | 11-deoxy acetylenic arylprostaglandins and their preparation | |
| GR61763B (en) | Preparation process of 2-substituted-5-alkyl resorcinols | |
| ZA766303B (en) | Disubstituted phenol ethers of 3-amino-2-hydroxypropane processes for their preparation and their use as medicament | |
| PH13199A (en) | Methods and pharmaceutical preparation for the treatment of hypercholesterolaenia | |
| GB1552333A (en) | Lanthanide phosphor and processes for its preparation | |
| IL50514A (en) | Clavulanic acid ethers their preparation and pharmaceutical compositions containing them | |
| PT64945A (en) | Preparation of therapeutic compounds | |
| JPS5277081A (en) | Pfnicillins process for preparing same and medical composition containing same | |
| JPS527419A (en) | Heterocolloidal deblicin containing medical composition and its preparation | |
| JPS51144720A (en) | Stable medical composition and its preparation of ergotalkaloids | |
| EG12318A (en) | Method for preparation of substituted(2-methylamino)thiazolin and uses as parasiticide | |
| JPS5218810A (en) | Complex medical composition of estrogennprostaglangin | |
| JPS5217454A (en) | Preparation and use of novel 22hydroxynaphthalinee 11aldehyde | |
| AU1076476A (en) | Preparation of 3-hydroxymethyl diphenyl ether | |
| JPS533509A (en) | Preparation of tumor vaccine | |
| JPS5223028A (en) | Preparation of alpha* alpha* alpha** alpha** alphaapentachlorooooxylol | |
| PH13439A (en) | Method of preparing solid pharmaceutical unit dosage form | |
| JPS5276416A (en) | Preparation of medical material with antiaggulutinating activity | |
| JPS51125330A (en) | Novel acetamidoximes* preparation thereof and medicine |